Synedica UK: Research Products, Peptides, Prices & Catalogue
If you are searching for Synedica UK, this guide brings together the key information surrounding the UK-focused research catalogue, peptide products, current listed prices, Retatrutide research materials and product information.
The UK-focused research resource provides information about peptide research materials, formulations and emerging biotechnology, with a catalogue covering several different research categories.
Whether you are researching individual products, comparing prices or looking for UK-specific product information, this page provides a starting point for navigating the catalogue.
What Is Synedica UK?
Synedica UK refers to the UK-focused research and product-information ecosystem surrounding the Synedica catalogue.
The current website describes itself as an independent UK-focused resource covering research materials, peptide formulations and emerging biotechnology. Its content is organised around individual compounds, product categories, formulation information and research resources.
For visitors searching commercially, the catalogue provides a central place to review available products, stated quantities and listed prices.
Synedica UK Research Products
The current catalogue includes products covering several research areas, including metabolic research, peptide research, skin-focused formulations, cellular signalling and other biotechnology-related categories.
Current catalogue listings include:
- Retatrutide 40mg research products
- CagriReta dual formulation
- CagriSema dual formulation
- Tirzepatide
- Semaglutide
- Somatotropin
- Klow Skin
- BPC-157 & TB-500
- NAD+ & NMN
- NAD+ & B12
- Biotin
- Glow Skin
- Melanotan II
- TRT & HCG
The catalogue currently displays 15 products across its shop, with prices varying by product and format.
Synedica UK Price Guide
Current catalogue prices provide useful reference points for researchers comparing different product formats.
| Product | Current listed price |
|---|---|
| Retatrutide 40mg Triple Agonist Pen | £110 |
| Retatrutide 40mg Bulk | £130–£6,200 |
| CagriReta Dual Pen | £120 |
| CagriSema Dual Pen | £80 |
| Klow Skin 80mg | £110 |
| Tirzepatide Dual Agonist Pen | £110 |
| Semaglutide Pen Kit | £115 |
| Somatotropin Pen Kit | £100 |
| BPC-157 & TB-500 Pen Kit | £100 |
| NAD+ & NMN Dual Action Pen | £100 |
| NAD+ & B12 Dual Action Pen | £100 |
| Biotin Pen | £100 |
| Glow Skin Multi-Peptide Pen | £115 |
| Melanotan II Nasal Spray | £50 |
These are catalogue prices observed on the current shop and can change. Always check the individual product page for the latest listing before making a purchasing decision.
Synedica Peptides UK
Peptide research is one of the major categories represented in the catalogue.
Peptides are studied across areas including receptor signalling, molecular interactions, cellular communication, metabolic pathways, tissue biology and formulation research.
The catalogue includes several peptide-related products and formulations, allowing researchers to investigate different compounds and combinations according to their individual research objectives.
However, a research listing should not automatically be interpreted as evidence that a product is an authorised medicine or approved treatment.
Synedica Retatrutide UK
Retatrutide is one of the most prominent research topics within the current catalogue.
The website lists a Retatrutide Triple Agonist Injection Pen Kit containing 40mg total at £110, alongside a separate 40mg bulk listing with displayed pricing from £130 to £6,200.
Retatrutide is an investigational compound studied for its activity across the GIP, GLP-1 and glucagon receptor pathways.
The current MHRA database records a paediatric investigation plan for retatrutide in relation to obesity, published on 16 July 2026. This is evidence of ongoing development activity and should not be interpreted as UK marketing authorisation.
Synedica UK Products: What Should You Compare?
When comparing research products, price should not be the only factor considered.
Researchers may want to compare:
Product identity
Check the exact product name and formulation.
Stated quantity
Confirm the amount stated in the product listing before comparing prices.
Product format
Different products may be presented as pens, sprays or other research formats.
Documentation
Review any available product information and analytical documentation.
Research-use conditions
Understand the intended research purpose and restrictions associated with the material.
Current pricing
Catalogue prices can change, so use the live product listing when checking current costs.
Why People Search for Synedica UK
The keyword Synedica UK can represent several different search intents.
Some visitors may be looking for:
- UK product information
- UK peptide research products
- Retatrutide research information
- Current catalogue prices
- 40mg Retatrutide pricing
- Bulk research products
- Product documentation
- Research peptide information
- UK-focused biotechnology resources
This makes the keyword useful as a broad category term connecting informational searches with commercial product research.
UK Research Product Catalogue
The current catalogue is organised around individual products and categories.
Visitors can use the shop to compare products by:
Name → formulation → stated quantity → price → research information
The catalogue currently includes a dedicated category for the broader product collection as well as a separate Retatrutide-related category.
For SEO and navigation, individual product pages should remain the primary destination for specific product searches, while this page acts as a broader UK research hub.
Is Retatrutide Approved in the UK?
Retatrutide remains under clinical development.
The MHRA’s current database lists retatrutide under a paediatric investigation plan relating to obesity, with the decision published in July 2026.
Therefore, research-product information should not be confused with UK marketing authorisation.
This distinction is particularly important when researching online listings for investigational compounds.
Research Use Only
The website states that its products and compounds are presented for scientific, educational and laboratory research purposes and are not presented as medicines, medical treatments, dietary supplements or consumer health products.
Research materials should therefore be evaluated according to their stated research purpose.
This page does not provide dosing instructions, treatment recommendations or medical advice.
Frequently Asked Questions
What is Synedica UK?
Synedica UK refers to the UK-focused research information and product catalogue covering peptide research materials, formulations and biotechnology-related products.
Where can I find UK product prices?
Current catalogue prices are displayed through the online shop and individual product pages. Prices may change, so the live listing should be checked before purchasing.
What is the price of Retatrutide 40mg in the UK catalogue?
The current catalogue lists the 40mg Retatrutide Triple Agonist Injection Pen at £110. A separate 40mg bulk listing currently displays £130–£6,200 depending on quantity.
What research peptides are listed?
The catalogue includes Retatrutide, BPC-157, TB-500, GHK-Cu-containing formulations and other peptide-related products.
Is retatrutide a UK-approved medicine?
The current MHRA record shows retatrutide remains in clinical development. An MHRA paediatric investigation plan does not itself constitute marketing authorisation.
Are these products intended for human use?
The website states that its research materials are for laboratory research and are not intended for human or veterinary use.
How can I compare research-product prices?
Compare the exact product, stated quantity, format, documentation and current catalogue price rather than relying solely on a headline price.
Final Summary
Synedica UK is a useful search term for visitors looking for UK-focused information about research products, peptides, formulations, pricing and biotechnology.
The current catalogue includes products across several research categories, with individual listings ranging from lower-priced products such as the £50 Melanotan II listing to higher-priced bulk Retatrutide options.
For Retatrutide specifically, the current catalogue lists the 40mg Triple Agonist Injection Pen at £110, while the separate 40mg bulk listing displays £130–£6,200.
For UK regulatory context, retatrutide remains under clinical development, and the current MHRA record should be consulted for regulatory information rather than treating commercial research listings as evidence of medicine authorisation.
Research-use notice: This page is provided for scientific and informational purposes. Research materials described here are not presented as medicines or medical treatments. This content does not provide medical advice, dosing instructions or recommendations for human or veterinary use.
